reactive oxygen species

Open Access
7,8-Diacetoxy-3-(4-methylsulfonylphenyl)-4-phenylcoumarin Induces ROS-dependent Cell Death in the A549 Human Lung Cancer Cell Line
MUSILIYU A. MUSA and QUDUS KOLAWOLE

Anticancer Research March 2023, 43 (3) 1001-1007; DOI: https://doi.org/10.21873/anticanres.16244
You have access
Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma Cells
PLOYPLOEN PHIKULSOD, RYUSHO KARIYA, JUTATIP PANAAMPON and SEIJI OKADA

Anticancer Research March 2023, 43 (3) 1139-1148; DOI: https://doi.org/10.21873/anticanres.16259
You have access
Redox-mediated Anticancer Activity of Anti-parasitic Drug Fenbendazole in Triple-negative Breast Cancer Cells
SEVERINA SEMKOVA, BILIANA NIKOLOVA, IANA TSONEVA, GEORGI ANTOV, DONIKA IVANOVA, ANTON ANGELOV, ZHIVKO ZHELEV and RUMIANA BAKALOVA

Anticancer Research March 2023, 43 (3) 1207-1212; DOI: https://doi.org/10.21873/anticanres.16267
Open Access
GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer
KEN SUGEZAWA, MASAKI MORIMOTO, MANABU YAMAMOTO, YOSHIAKI MATSUMI, YUJI NAKAYAMA, KAZUSHI HARA, CHIHIRO UEJIMA, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, NARUO TOKUYASU, TERUHISA SAKAMOTO, YOSHIHISA UMEKITA and YOSHIYUKI FUJIWARA

Anticancer Research December 2022, 42 (12) 5719-5729; DOI: https://doi.org/10.21873/anticanres.16079
You have access
The γ-Glutamylcyclotransferase Inhibitor Pro-GA Induces an Antiproliferative Effect Through the Generation of Mitochondrial Reactive Oxygen Species
HIROMI II, KEIKO TANIGUCHI, TAKU YOSHIYA, YUKIE NOHARA, SUSUMU KAGEYAMA, AKIHIRO KAWAUCHI and SUSUMU NAKATA

Anticancer Research September 2022, 42 (9) 4311-4317; DOI: https://doi.org/10.21873/anticanres.15931
You have access
Administration of Gapmer-type Antisense Oligonucleotides Targeting γ-Glutamylcyclotransferase Suppresses the Growth of A549 Lung Cancer Xenografts
HIROMI II, YUUYA KASAHARA, HARUMI YAMAGUMA, SUSUMU KAGEYAMA, AKIHIRO KAWAUCHI, SATOSHI OBIKA and SUSUMU NAKATA

Anticancer Research March 2022, 42 (3) 1221-1227; DOI: https://doi.org/10.21873/anticanres.15589
You have access
Evaluation of Erastin as a Therapeutic Agent Under Hypoxic Conditions in Pancreatic Cancer Cells
SATOSHI OWADA, HITOSHI ENDO, YUKARI SHIDA, TAKAAKI KINOUE, HIROYUKI FURUYA and MASAYUKI TATEMICHI

Anticancer Research December 2021, 41 (12) 6051-6059; DOI: https://doi.org/10.21873/anticanres.15424
You have access
Evaluation of the Cytotoxic Effects of the Novel Antineoplastic Agent 1,4,5-Oxathiazinane-4,4-dioxide on Triple Negative Breast Cancer Cells
MARCEL JINIH, JIANG HUAI WANG, ROLF W. PFIRRMANN, D. PETER O’LEARY, MARK A. CORRIGAN and H. PAUL REDMOND

Anticancer Research May 2021, 41 (5) 2247-2256; DOI: https://doi.org/10.21873/anticanres.15001
You have access
Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells
YONG-ZHE JIN, YI-XI GONG, YUE LIU, DAN-PING XIE, CHEN-XI REN, SEUNG-JAE LEE, HU-NAN SUN, TAEHO KWON and DONG-YUAN XU

Anticancer Research April 2021, 41 (4) 1831-1840; DOI: https://doi.org/10.21873/anticanres.14949
You have access
Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines
UNCHALEE THONSRI, WUNCHANA SEUBWAI, SAKDA WARAASAWAPATI, SOPIT WONGKHAM, THIDARAT BOONMARS, UBON CHA'ON and CHAISIRI WONGKHAM

Anticancer Research September 2020, 40 (9) 5115-5124; DOI: https://doi.org/10.21873/anticanres.14515

Main menu

User menu

Search

reactive oxygen species

Pages